Liver News and Research

RSS

Study highlights potential health impact of zero-calorie sweeteners

As a sugar substitute, zero-calorie sweeteners may reduce tooth decay and blood sugar spikes. Seven are approved worldwide and safe for humans - but does this mean they're healthy?

26 Jun 2019

AASLD Foundation awards $3.42 million for liver disease research and advanced hepatology training

The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.42 million in Research and Career Development Awards granted to 29 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.

25 Jun 2019

Veterans with PTSD twice as likely to die from suicide, accidental injury, and viral hepatitis

According to a new study in the American Journal of Preventive Medicine, published by Elsevier, United States Veterans seeking treatment for posttraumatic stress disorder are at increased risk of death compared with the general population.

24 Jun 2019

New study could change our understanding of how stem cells differentiate

A pioneering new study led by Florida State University biologists could fundamentally change our understanding of how embryonic stem cells differentiate into specific cell types.

24 Jun 2019

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.

22 Jun 2019

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

For decades, University Distinguished Professor of Molecular Virology X.J. Meng and his lab at the Virginia-Maryland College of Veterinary Medicine have studied hepatitis E virus (HEV), the causative agent of hepatitis E in humans.

21 Jun 2019

New findings offer pathway for fight against non-alcoholic fatty liver disease

A research group from the Medical University of Vienna was able to decode the mechanism as to how the hormone Leptin stimulates the liver to export lipids and reduce the fat production in the liver.

21 Jun 2019

Legal weed’s a growing danger to dogs, so keep your canine out of your cannabis

It all started on a Tuesday night, when I came home from work to an unmistakable absence. My brown-and-white pitbull mix, Maizey, wasn’t at the top of the stairs to greet me. Instead, she was in her bed, shaky and confused.

21 Jun 2019

Study uncovers impact of both low and high iron counts

A global study looking at the role that iron plays in 900 diseases has uncovered the impact of both low and high iron counts – and the news is mixed.

21 Jun 2019

Vitamin D supplementation may not reduce the risk of heart disease

Scientists have confirmed that taking vitamin D supplements does not reduce the risk of cardiovascular disease.

20 Jun 2019

Study finds link between poor oral health and increased risk of liver cancer

Poor oral health is associated with a 75% increased risk of hepatocellular carcinoma, the most common form of liver cancer, new research published in UEG Journal has found.

20 Jun 2019

Dangerous brain parasite invades host cell, maintains steady nutrient supply

A team of researchers has found that a dangerous type of parasite that affects the brain, maintains a stable supply of essential nutrients as it replicates in the host cell. In an unexpected turn of events, the body itself delivers food to the harmful predator.

20 Jun 2019

Researchers identify genes linked with survival in children with biliary atresia

Scientists at Cincinnati Children's Hospital Medical Center have identified an expression pattern of 14 genes at the time of diagnosis that predicts two year, transplant-free survival in children with biliary atresia – the most common diagnosis leading to liver transplants in children.

19 Jun 2019

Yale researchers offer insight into the hunger hormone

In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity. Their findings advance knowledge about leptin and weight gain, and also suggest a potential strategy for developing future weight-loss treatments, they said.

19 Jun 2019

Researchers find possible counterpunch to drug resistance of melanoma

Researchers at Oregon State University and Oregon Health & Science University have found a possible counterpunch to the drug resistance of melanoma, the most dangerous form of skin cancer.

19 Jun 2019

Researchers identify genetic mutation that causes fatal response to HAV infection

Researchers have identified a genetic mutation that caused an 11-year-old girl to suffer a fatal reaction to infection with the Hepatitis A virus.

18 Jun 2019

Scientists develop new class of drugs to treat hereditary kidney disease

Scientists from the University of Sheffield are part of an international collaboration to develop a new class of drugs to treat a common genetic kidney disease which is a major cause of kidney failure.

18 Jun 2019

Up to 80% of metastatic colorectal cancers spread to far areas before diagnoses

Up to 80% of metastatic colorectal cancers are likely to have spread to distant locations in the body before the original tumor has exceeded the size of a poppy seed, according to a study of nearly 3,000 patients by researchers at the Stanford University School of Medicine.

18 Jun 2019

Scientists describe microbiome composition in patients suffering from IBD and PSC

In 2012, Professor Jeroen Raes launched the Flemish Gut Flora Project. Sequencing fecal samples of over 3,000 healthy volunteers, Prof. Raes and his team defined the boundaries of a normal, health-associated gut microbiota.

18 Jun 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Liver News and Research

Study highlights potential health impact of zero-calorie sweeteners

AASLD Foundation awards $3.42 million for liver disease research and advanced hepatology training

Veterans with PTSD twice as likely to die from suicide, accidental injury, and viral hepatitis

New study could change our understanding of how stem cells differentiate

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

New findings offer pathway for fight against non-alcoholic fatty liver disease

Legal weed’s a growing danger to dogs, so keep your canine out of your cannabis

Study uncovers impact of both low and high iron counts

Vitamin D supplementation may not reduce the risk of heart disease

Study finds link between poor oral health and increased risk of liver cancer

Dangerous brain parasite invades host cell, maintains steady nutrient supply

Researchers identify genes linked with survival in children with biliary atresia

Yale researchers offer insight into the hunger hormone

Researchers find possible counterpunch to drug resistance of melanoma

Researchers identify genetic mutation that causes fatal response to HAV infection

Scientists develop new class of drugs to treat hereditary kidney disease

Up to 80% of metastatic colorectal cancers spread to far areas before diagnoses

Scientists describe microbiome composition in patients suffering from IBD and PSC

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News